Laurence J, Kulkosky J, Friedman S M, Posnett D N, Ts'o P O
Laboratory for Acquired Immunodeficiency Syndrome (AIDS) Research, Hospital for Special Surgery, New York, New York.
J Clin Invest. 1987 Dec;80(6):1631-9. doi: 10.1172/JCI113251.
Two alloreactive human CD4+ T cell clones, recognizing HLA-DR2 and HLA-DR1 determinants, lost their specific proliferative capacity after infection with HIV. This system was used to explore the effect of polyI.polyC12U on HIV replication and immune suppression. The mismatched double-stranded RNA blocked HIV-associated particulate reverse transcriptase activity and viral-mediated cytopathic effects. Also, polyI.polyC12U preserved the alloreactivity of T cell clones after exposure to HIV.PolyI.polyC12U appeared to act at a level subsequent to host cell infection and reverse transcription. It had no effect on the enhancement of gene expression by the HIV transcription unit tatIII. These findings indicate that early in the course of infection of CD4+ T lymphocytes, HIV can directly abrogate proliferation to specific allodeterminants, and that this function is preserved in the presence of polyI.polyC12U. They also provide insight into the mechanism of antiviral action of a class of agent with potential clinical utility in AIDS.
两个识别HLA - DR2和HLA - DR1决定簇的同种异体反应性人类CD4 + T细胞克隆在感染HIV后丧失了其特异性增殖能力。该系统被用于探究聚肌苷酸 - 聚胞苷酸12尿苷(polyI.polyC12U)对HIV复制和免疫抑制的影响。错配双链RNA阻断了HIV相关的颗粒性逆转录酶活性以及病毒介导的细胞病变效应。此外,polyI.polyC12U在T细胞克隆暴露于HIV后保留了其同种异体反应性。PolyI.polyC12U似乎在宿主细胞感染和逆转录之后的水平发挥作用。它对HIV转录单元tatIII增强基因表达没有影响。这些发现表明,在CD4 + T淋巴细胞感染过程的早期,HIV可直接消除对特定同种异体决定簇的增殖反应,并且在polyI.polyC12U存在的情况下该功能得以保留。它们还为一类在艾滋病中具有潜在临床应用价值的药物的抗病毒作用机制提供了见解。